Shanghai HeartCare Medical Technology Corporation Limited announced unaudited consolidated earnings results for the six months ended June 30, 2021. For the six months, the company's revenue was RMB 30,125,000 compared to RMB 2,171,000 a year ago. Loss for the period was RMB 93,671,000 compared to RMB 15,834,000 a year ago. Basic and diluted loss per share was RMB 3.02 compared to RMB 0.77 a year ago.